Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1984-04-27
1986-10-07
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424 71, 436 63, G01N 130, G01N 3349, G01N 3352
Patent
active
046158782
ABSTRACT:
Differentiation, identification and enumeration of sub-populations of lymphocytes including B-cells and T-cells can now be further discriminated into their sub-populations by means of basic orange 21 as a supravital stain to provide distinctive morphologic differences between B-cells, T-suppressor cells, T-helper cells and natural killer (NK) cells without resorting to the use of individual monoclonal antibodies for differentiation of each of the above.
The differentiation, identification and enumeration of the foregoing cells can be accomplished by means of both white light absorbance and fluorescence measurements, singly or in sequential combinations.
REFERENCES:
patent: 2126852 (1938-08-01), Wolff
patent: 3617185 (1971-11-01), Drautz
patent: 4146604 (1979-03-01), Kleinerman
patent: 4390518 (1983-06-01), Fischer
patent: 4400370 (1983-08-01), Kass
patent: 4492752 (1985-01-01), Hoffman
patent: 4500509 (1985-02-01), Kass
patent: 4581223 (1986-04-01), Kass
Lanier et al. (1983), J. of Immunology 131(4): 1789-1796.
Foulke Cynthia Lee
Nucker Christine M.
Smith Richard G.
LandOfFree
Metachromatic dye sorption means for differential determination does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metachromatic dye sorption means for differential determination , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metachromatic dye sorption means for differential determination will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-642376